decisionhealth Newsletters, Part B News - 2002 Issue 4 (April)
More tips from CMS on 'protime' test
Subscribe or sign in to view the full article.
Article Overview
This article summarizes CMS comments on billing for protime testing and related patient visits in office and clinic settings. It is aimed at coders, billers, and compliance staff who handle laboratory-related encounter reporting and need to understand the general scope of CMS guidance, Medicare policy context, and when additional evaluation services may be considered separately. The article also notes the settings and service scenarios discussed by CMS, including freestanding clinics and routine review of lab results.
Why This Topic Matters
It helps readers recognize the billing context CMS is addressing for laboratory follow-up visits and avoid misclassifying routine test review versus separately reportable evaluation services.
Article Sections
-
Billing guidance for protime testing
Overview of CMS comments on reporting services associated with protime testing and related patient encounters. Covers the general billing context and the setting in which the guidance is discussed.
-
CMS comments on clinic and office settings
Discussion of how the CMS remarks apply to routine review of laboratory results, medically necessary evaluation, and services performed in clinic or office-based environments. Also notes the Medicare policy context mentioned in the article.
What You Will Learn
- The general CMS billing context for protime-related services
- How the article frames separate evaluation services in relation to test follow-up
- Which settings are discussed for the reported guidance
- What policy context CMS associates with these clinic visits
Who Should Read This
- Medical coders
- Medical billers
- Compliance staff
- Office managers
- Clinic administrators
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com